ZYBT
Zhengye Biotechnology Holding Limited
1.30$
+5.0%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 41.4% | 41.0% | 38.6% | 51.0% | 79.5% | |
| 58.6% | 59.0% | 61.4% | 49.0% | 20.5% | |
| 5.3% | 5.2% | 5.6% | 6.9% | 15.5% | |
| 10.4% | 11.1% | 12.2% | 34.3% | 26.6% | |
| 34.1% | 33.7% | 40.1% | 90.8% | 79.2% | |
| 24.5% | 25.3% | 21.3% | 9.2% | -58.7% | |
| 0.5% | 1.1% | 2.1% | 2.2% | 2.9% | |
| 24.8% | 24.6% | 20.7% | 7.7% | -61.8% | |
| 3.1% | 3.1% | 3.0% | – | 9.5% | |
| 18.2% | 18.0% | 14.9% | 6.1% | -60.0% | |
| 32.8% | 32.9% | 34.1% | – | -36.5% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.